Company / Tangible Book Value per Share
Idexx Laboratories Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$14.60
FY2025
5-year range
$2.92 / $14.60
FY2021-FY2025
Trend
+1.8%
vs FY2024
Sector context
#38 of 163
Health Care
What the data says
Idexx Laboratories's tangible book value per share of $14.60 is higher than 77% of companies in the Health Care sector (FY2025). Tangible Book Value per Share has increased for 3 consecutive years, from $2.92 in FY2022 to $14.60 in FY2025.
Based on SEC 10-K filings.
14.60 in FY2025 with a 5-year CAGR of +26.3%. Top quartile in the Health Care sector.
Improved from $13.49 to $14.60 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +71.0%
- 5-Year CAGR
- +26.3%
- 10-Year CAGR
- -
Sector benchmark
-19.7% below sector average
Key checks
Key Insights
- Idexx Laboratories's tangible book value per share has grown for 3 consecutive years.
- In FY2025, tangible book value per share increased 1.8% year-over-year.
- Ranks #38 out of 163 companies in the Health Care sector.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.60 | +1.8% |
| FY2024 | $14.33 | +6.2% |
| FY2023 | $13.49 | +362.1% |
| FY2022 | $2.92 | -24.5% |
| FY2021 | $3.87 | -14.9% |
| FY2020 | $4.55 | +729.1% |
| FY2019 | -$0.72 | +71.9% |
| FY2018 | -$2.57 | +5.2% |
| FY2017 | -$2.71 | +3.9% |
| FY2016 | -$2.82 | -15.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026